about
Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor modelThe hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsThe dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitorsTargeting of erbB3 receptor to overcome resistance in cancer treatmentA novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathPI3K/PTEN signaling in angiogenesis and tumorigenesisUbiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4Anti-Tumor Effect of Pinus massoniana Bark Proanthocyanidins on Ovarian Cancer through Induction of Cell Apoptosis and Inhibition of Cell MigrationSORBS1 suppresses tumor metastasis and improves the sensitivity of cancer to chemotherapy drugMetastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.Learning therapeutic lessons from metastasis suppressor proteins.Signal-regulated Pre-mRNA occupancy by the general splicing factor U2AF.Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumorsPhosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro studyInvolvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis.Reexpression of LGI1 in glioma cells results in dysregulation of genes implicated in the canonical axon guidance pathway.Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cellsIdentification of gene markers associated with metastasis in clear cell renal cell carcinoma.Isorhynchophylline, a Potent Plant Alkaloid, Induces Apoptotic and Anti-Metastatic Effects in Human Hepatocellular Carcinoma Cells through the Modulation of Diverse Cell Signaling Cascades.ERBB2 increases metastatic potentials specifically in androgen-insensitive prostate cancer cells.FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.A monoclonal antibody (Mc178-Ab) targeted to the ecto-ATP synthase β-subunit-induced cell apoptosis via a mechanism involving the MAPKase and Akt pathways.MUC13 mucin augments pancreatic tumorigenesis.Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expressionGene expression profile of esophageal cancer in North East India by cDNA microarray analysis.Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of BaxOncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesisOverexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB.Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells.Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production.Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cellsThe antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation.A molecular link between E2F-1 and the MAPK cascade.Role of glycosyltransferase PomGnT1 in glioblastoma progression.Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier.
P2860
Q21133610-CA938107-7366-4BED-B75C-FD6928EA692AQ24595836-C8D727B7-AAB6-4279-AB33-63F2A1324513Q24651992-09399572-0958-4904-BB47-9D2325508F7CQ26864668-332AB8B4-9CBA-470A-ADA3-71C18A6D2828Q27321296-6ADC294B-23F1-4DBF-B383-0717958512BAQ28080874-174D3FD5-7EF1-4AB2-961E-A8CD9ACE70D6Q28383083-7703DF18-3C8E-4D13-A1F2-DD0DF9C9AE8AQ28390715-1031E332-7B4F-4E3C-A04F-EA833D5C963EQ28550710-E11E3A60-3683-4C2D-B219-9530E1658AA4Q30008832-A7046A7F-8535-4422-916E-2398AFFDF42DQ30371232-862170B9-AE7C-411C-BAC5-512929F9A01CQ30435922-9E602998-36F5-42B7-96FF-66EDD5A054A3Q33313872-F5FC3D66-953D-4A41-89B4-3B27E4F7DCCFQ33385005-F467E6D5-EC8E-4294-B277-24EE440F0D6DQ33495790-99F7EEBD-4291-4CAD-9D52-5539EB2A01B1Q33529782-095A5B5E-A0AF-41A2-9B61-825E5D448B9FQ33603725-11AF749F-5CA4-4078-8934-80DDA5741FD0Q33653166-571D605E-31E6-47E2-BCEB-D28D6CBA74DDQ33746852-E096CB4A-0A9D-478F-A2F0-E3DA89608CF8Q33751311-4997FB83-4833-47A8-A122-C71757EA2A22Q33755460-27285643-1D2E-49DD-B1AF-E68633879024Q33768865-EA113DE8-5FB3-4407-8D19-942B88C903A1Q33784587-BB05A28E-63E2-46E3-BE03-55CB3528FB2FQ33840435-B486C009-54E9-4666-99BB-AE20E3C5FE49Q33877325-49B7A883-D8E0-4096-A202-AE3680736DE7Q33909073-6F2C98C1-236D-452D-81AE-10F3F99BE605Q33918409-2ADAE38D-0765-4493-B225-230A24EE7423Q34099305-E943FCBB-B2D8-4C1D-B5FC-E532A1230068Q34152658-29EB3E17-D554-4F06-8276-6C83BD088D31Q34161250-F3AA2707-B284-4889-A82F-903962665599Q34252160-E0968D3A-8FB6-43BB-90C2-90372D261CDFQ34258429-F05DCB7C-CE6B-4505-8C1B-ED17EC2CFDF8Q34282044-51361467-FF5F-4F5D-9CE1-DA66FC9F1A74Q34363873-258D96BB-BE51-4998-A372-46E376B28F51Q34485591-16B2C0F9-2596-42ED-91FF-084D9B3BA9E7Q34598936-C4C37CE8-2E6D-4610-ACA7-AF05CD3A6374Q34599215-2E97669F-9C64-4F76-8431-36DC73BAA31BQ34621769-9B699945-940B-4B4A-9C99-C26AAF9A54DFQ34886810-07464CCB-DABE-4E24-AACD-419A73D40184Q34975148-4CA3DE9F-496C-47E1-BAF0-54F756322811
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of MAP kinase in tumor progression and invasion.
@ast
Role of MAP kinase in tumor progression and invasion.
@en
type
label
Role of MAP kinase in tumor progression and invasion.
@ast
Role of MAP kinase in tumor progression and invasion.
@en
prefLabel
Role of MAP kinase in tumor progression and invasion.
@ast
Role of MAP kinase in tumor progression and invasion.
@en
P2093
P356
P1476
Role of MAP kinase in tumor progression and invasion.
@en
P2093
Kaladhar B Reddy
Natasha Atanaskova
Sanaa M Nabha
P2888
P304
P356
10.1023/A:1023781114568
P577
2003-12-01T00:00:00Z
P5875
P6179
1005802135